Share Price and Basic Stock Data
Last Updated: March 7, 2025, 3:27 pm
| PEG Ratio | 6.46 |
|---|
Competitors of Colgate-Palmolive (India) Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Honasa Consumer Ltd | 7,271 Cr. | 224 | 547/197 | 107 | 35.5 | 0.00 % | 17.1 % | % | 10.0 |
| Ambica Agarbathies Aroma & Industries Ltd | 50.7 Cr. | 29.8 | 37.0/23.2 | 19.1 | 60.6 | 0.00 % | 5.07 % | 3.65 % | 10.0 |
| Ador Multi Products Ltd | 12.5 Cr. | 26.7 | 45.9/23.4 | 23.2 | 0.00 % | 33.6 % | 26.7 % | 10.0 | |
| Kaya Ltd | 311 Cr. | 237 | 702/218 | 106 | 0.00 % | 80.4 % | % | 10.0 | |
| Jyothy Labs Ltd | 12,111 Cr. | 330 | 596/310 | 32.5 | 51.4 | 1.06 % | 27.0 % | 21.2 % | 1.00 |
| Industry Average | 66,733.93 Cr | 1,892.78 | 47.07 | 109.30 | 0.81% | 36.43% | 29.37% | 4.94 |
Quarterly Result
| Metric | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,280 | 1,301 | 1,197 | 1,387 | 1,291 | 1,351 | 1,324 | 1,471 | 1,396 | 1,490 | 1,497 | 1,619 | 1,462 |
| Expenses | 900 | 872 | 871 | 979 | 930 | 899 | 906 | 989 | 927 | 958 | 988 | 1,122 | 1,007 |
| Operating Profit | 381 | 429 | 326 | 408 | 361 | 452 | 418 | 482 | 468 | 532 | 508 | 497 | 454 |
| OPM % | 30% | 33% | 27% | 29% | 28% | 33% | 32% | 33% | 34% | 36% | 34% | 31% | 31% |
| Other Income | 6 | 9 | 2 | 11 | 10 | 18 | -5 | 21 | 18 | 23 | 23 | 76 | 20 |
| Interest | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 |
| Depreciation | 44 | 44 | 44 | 44 | 44 | 43 | 44 | 44 | 41 | 42 | 42 | 42 | 41 |
| Profit before tax | 341 | 393 | 282 | 374 | 327 | 426 | 369 | 458 | 443 | 511 | 489 | 530 | 433 |
| Tax % | 26% | 18% | 26% | 26% | 26% | 26% | 26% | 26% | 26% | 26% | 26% | 26% | 25% |
| Net Profit | 252 | 324 | 210 | 278 | 243 | 316 | 274 | 340 | 330 | 380 | 364 | 395 | 323 |
| EPS in Rs | 9.28 | 11.90 | 7.71 | 10.22 | 8.94 | 11.63 | 10.06 | 12.50 | 12.14 | 13.96 | 13.38 | 14.52 | 11.87 |
Last Updated: February 28, 2025, 8:46 pm
Below is a detailed analysis of the quarterly data for Colgate-Palmolive (India) Ltd based on the most recent figures (Dec 2024) and their trends compared to the previous period:
- For Sales, as of Dec 2024, the value is ₹1,462.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,619.00 Cr. (Sep 2024) to ₹1,462.00 Cr., marking a decrease of 157.00 Cr..
- For Expenses, as of Dec 2024, the value is ₹1,007.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 1,122.00 Cr. (Sep 2024) to ₹1,007.00 Cr., marking a decrease of 115.00 Cr..
- For Operating Profit, as of Dec 2024, the value is ₹454.00 Cr.. The value appears to be declining and may need further review. It has decreased from 497.00 Cr. (Sep 2024) to ₹454.00 Cr., marking a decrease of 43.00 Cr..
- For OPM %, as of Dec 2024, the value is 31.00%. The value remains steady. There is no change compared to the previous period (Sep 2024) which recorded 31.00%.
- For Other Income, as of Dec 2024, the value is ₹20.00 Cr.. The value appears to be declining and may need further review. It has decreased from 76.00 Cr. (Sep 2024) to ₹20.00 Cr., marking a decrease of 56.00 Cr..
- For Interest, as of Dec 2024, the value is ₹1.00 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2024) which recorded 1.00 Cr..
- For Depreciation, as of Dec 2024, the value is ₹41.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 42.00 Cr. (Sep 2024) to ₹41.00 Cr., marking a decrease of 1.00 Cr..
- For Profit before tax, as of Dec 2024, the value is ₹433.00 Cr.. The value appears to be declining and may need further review. It has decreased from 530.00 Cr. (Sep 2024) to ₹433.00 Cr., marking a decrease of 97.00 Cr..
- For Tax %, as of Dec 2024, the value is 25.00%. The value appears to be improving (decreasing) as expected. It has decreased from 26.00% (Sep 2024) to 25.00%, marking a decrease of 1.00%.
- For Net Profit, as of Dec 2024, the value is ₹323.00 Cr.. The value appears to be declining and may need further review. It has decreased from 395.00 Cr. (Sep 2024) to ₹323.00 Cr., marking a decrease of 72.00 Cr..
- For EPS in Rs, as of Dec 2024, the value is 11.87. The value appears to be declining and may need further review. It has decreased from ₹14.52 (Sep 2024) to 11.87, marking a decrease of ₹2.65.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: March 7, 2025, 9:28 pm
| Metric | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 3,164 | 3,579 | 3,982 | 3,868 | 3,982 | 4,188 | 4,462 | 4,525 | 4,841 | 5,100 | 5,226 | 5,680 | 6,068 |
| Expenses | 2,505 | 2,915 | 3,159 | 2,929 | 3,038 | 3,074 | 3,226 | 3,323 | 3,331 | 3,534 | 3,679 | 3,779 | 4,075 |
| Operating Profit | 659 | 664 | 823 | 940 | 944 | 1,114 | 1,236 | 1,202 | 1,510 | 1,566 | 1,547 | 1,901 | 1,992 |
| OPM % | 21% | 19% | 21% | 24% | 24% | 27% | 28% | 27% | 31% | 31% | 30% | 33% | 33% |
| Other Income | 48 | 115 | 32 | 7 | 41 | 26 | 68 | 49 | 30 | 26 | 42 | 57 | 142 |
| Interest | -0 | -0 | -0 | -0 | -0 | -0 | 2 | 10 | 7 | 6 | 5 | 5 | 5 |
| Depreciation | 44 | 51 | 75 | 111 | 133 | 157 | 159 | 198 | 182 | 177 | 175 | 172 | 166 |
| Profit before tax | 663 | 728 | 780 | 835 | 851 | 983 | 1,143 | 1,043 | 1,350 | 1,409 | 1,410 | 1,781 | 1,964 |
| Tax % | 25% | 26% | 28% | 30% | 32% | 32% | 32% | 22% | 23% | 23% | 26% | 26% | |
| Net Profit | 497 | 540 | 559 | 581 | 577 | 673 | 776 | 816 | 1,035 | 1,078 | 1,047 | 1,324 | 1,462 |
| EPS in Rs | 18.26 | 19.85 | 20.55 | 21.37 | 21.23 | 24.76 | 28.52 | 30.02 | 38.07 | 39.65 | 38.50 | 48.67 | 53.73 |
| Dividend Payout % | 77% | 68% | 58% | 47% | 47% | 97% | 81% | 93% | 100% | 101% | 101% | 119% |
YoY Net Profit Growth
| Year | 2013-2014 | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 8.65% | 3.52% | 3.94% | -0.69% | 16.64% | 15.30% | 5.15% | 26.84% | 4.15% | -2.88% | 26.46% |
| Change in YoY Net Profit Growth (%) | 0.00% | -5.13% | 0.42% | -4.62% | 17.33% | -1.33% | -10.15% | 21.68% | -22.68% | -7.03% | 29.33% |
Colgate-Palmolive (India) Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2013-2014 to 2023-2024.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 5% |
| 5 Years: | 5% |
| 3 Years: | 5% |
| TTM: | 10% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 12% |
| 3 Years: | 9% |
| TTM: | 15% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 9% |
| 5 Years: | 15% |
| 3 Years: | 18% |
| 1 Year: | -4% |
| Return on Equity | |
|---|---|
| 10 Years: | 63% |
| 5 Years: | 68% |
| 3 Years: | 70% |
| Last Year: | 75% |
Last Updated: Unknown
Balance Sheet
Last Updated: October 26, 2024, 2:57 pm
| Month | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 14 | 14 | 14 | 27 | 27 | 27 | 27 | 27 | 27 | 27 | 27 | 27 | 27 |
| Reserves | 476 | 586 | 757 | 1,004 | 1,247 | 1,497 | 1,420 | 1,567 | 1,139 | 1,707 | 1,689 | 1,847 | 1,626 |
| Borrowings | 0 | 0 | 0 | 0 | 0 | 0 | 83 | 102 | 91 | 83 | 69 | 72 | 70 |
| Other Liabilities | 817 | 894 | 932 | 972 | 1,037 | 1,039 | 1,097 | 908 | 1,637 | 1,084 | 1,098 | 1,250 | 1,525 |
| Total Liabilities | 1,307 | 1,493 | 1,702 | 2,003 | 2,311 | 2,564 | 2,626 | 2,604 | 2,894 | 2,902 | 2,883 | 3,197 | 3,248 |
| Fixed Assets | 281 | 556 | 782 | 1,008 | 1,108 | 1,146 | 1,191 | 1,123 | 1,065 | 963 | 862 | 794 | 822 |
| CWIP | 102 | 142 | 141 | 78 | 167 | 159 | 199 | 190 | 145 | 122 | 114 | 110 | 31 |
| Investments | 47 | 37 | 37 | 31 | 31 | 31 | 31 | 19 | 19 | 0 | 0 | 0 | 0 |
| Other Assets | 877 | 759 | 742 | 885 | 1,005 | 1,228 | 1,206 | 1,272 | 1,666 | 1,817 | 1,907 | 2,292 | 2,395 |
| Total Assets | 1,307 | 1,493 | 1,702 | 2,003 | 2,311 | 2,564 | 2,626 | 2,604 | 2,894 | 2,902 | 2,883 | 3,197 | 3,248 |
Below is a detailed analysis of the balance sheet data for Colgate-Palmolive (India) Ltd based on the most recent figures (Sep 2024) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2024, the value is ₹27.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded ₹27.00 Cr..
- For Reserves, as of Sep 2024, the value is ₹1,626.00 Cr.. The value appears to be declining and may need further review. It has decreased from ₹1,847.00 Cr. (Mar 2024) to ₹1,626.00 Cr., marking a decrease of 221.00 Cr..
- For Borrowings, as of Sep 2024, the value is ₹70.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from ₹72.00 Cr. (Mar 2024) to ₹70.00 Cr., marking a decrease of 2.00 Cr..
- For Other Liabilities, as of Sep 2024, the value is ₹1,525.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from ₹1,250.00 Cr. (Mar 2024) to ₹1,525.00 Cr., marking an increase of 275.00 Cr..
- For Total Liabilities, as of Sep 2024, the value is ₹3,248.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from ₹3,197.00 Cr. (Mar 2024) to ₹3,248.00 Cr., marking an increase of 51.00 Cr..
- For Fixed Assets, as of Sep 2024, the value is ₹822.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹794.00 Cr. (Mar 2024) to ₹822.00 Cr., marking an increase of 28.00 Cr..
- For CWIP, as of Sep 2024, the value is ₹31.00 Cr.. The value appears to be declining and may need further review. It has decreased from ₹110.00 Cr. (Mar 2024) to ₹31.00 Cr., marking a decrease of 79.00 Cr..
- For Investments, as of Sep 2024, the value is ₹0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded ₹0.00 Cr..
- For Other Assets, as of Sep 2024, the value is ₹2,395.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹2,292.00 Cr. (Mar 2024) to ₹2,395.00 Cr., marking an increase of 103.00 Cr..
- For Total Assets, as of Sep 2024, the value is ₹3,248.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹3,197.00 Cr. (Mar 2024) to ₹3,248.00 Cr., marking an increase of 51.00 Cr..
Notably, the Reserves (₹1,626.00 Cr.) exceed the Borrowings (70.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 659.00 | 664.00 | 823.00 | 940.00 | 944.00 | 1.00 | -82.00 | -101.00 | -90.00 | -82.00 | -68.00 | -71.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 9 | 6 | 6 | 10 | 12 | 18 | 17 | 11 | 9 | 16 | 11 | 11 |
| Inventory Days | 54 | 59 | 63 | 72 | 72 | 56 | 58 | 69 | 79 | 78 | 68 | 63 |
| Days Payable | 136 | 130 | 128 | 136 | 148 | 152 | 144 | 142 | 179 | 169 | 155 | 187 |
| Cash Conversion Cycle | -73 | -65 | -59 | -55 | -63 | -79 | -68 | -63 | -91 | -75 | -76 | -113 |
| Working Capital Days | -49 | -47 | -40 | -43 | -39 | -33 | -36 | -21 | -83 | -24 | -31 | -45 |
| ROCE % | 144% | 122% | 114% | 96% | 74% | 71% | 73% | 65% | 92% | 92% | 79% | 97% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| Nippon India Multi Cap Fund | 500,473 | 0.49 | 135.65 | 169,458 | 2025-03-08 | 195.34% |
| Nippon India Large Cap Fund | 497,594 | 0.55 | 134.87 | 169,458 | 2025-03-08 | 193.64% |
| Franklin India Prima Fund | 450,000 | 1.21 | 121.97 | 169,458 | 2025-03-08 | 165.55% |
| NJ Balanced Advantage Fund | 345,381 | 2.36 | 93.61 | 169,458 | 2025-03-08 | 103.82% |
| Nippon India ETF Nifty Next 50 Junior BeES | 341,321 | 1.98 | 92.51 | 169,458 | 2025-03-08 | 101.42% |
| NJ Flexi Cap Fund | 187,246 | 4.68 | 50.75 | 169,458 | 2025-03-08 | 10.5% |
| Franklin India Equity Advantage Fund | 169,458 | 1.46 | 45.93 | 169,458 | 2025-03-08 | 0% |
| Axis Growth Opportunities Fund | 123,167 | 0.28 | 33.38 | 169,458 | 2025-03-08 | -27.32% |
| Baroda BNP Paribas Midcap Fund | 105,000 | 1.59 | 28.46 | 169,458 | 2025-03-08 | -38.04% |
| Templeton India Equity Income Fund | 100,000 | 1.31 | 27.1 | 169,458 | 2025-03-08 | -40.99% |
Key Financial Ratios
| Month | Mar 24 | Mar 23 | Mar 22 | Mar 21 | Mar 20 |
|---|---|---|---|---|---|
| FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Basic EPS (Rs.) | 48.67 | 38.50 | 39.65 | 38.07 | 30.02 |
| Diluted EPS (Rs.) | 48.67 | 38.50 | 39.65 | 38.07 | 30.02 |
| Cash EPS (Rs.) | 54.97 | 44.93 | 46.16 | 44.78 | 37.30 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 68.91 | 63.11 | 63.78 | 42.86 | 58.61 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 68.91 | 63.11 | 63.78 | 42.86 | 58.61 |
| Dividend / Share (Rs.) | 58.00 | 39.00 | 40.00 | 38.00 | 28.00 |
| Revenue From Operations / Share (Rs.) | 208.85 | 192.15 | 187.50 | 178.00 | 166.37 |
| PBDIT / Share (Rs.) | 72.70 | 58.85 | 58.54 | 56.62 | 45.99 |
| PBIT / Share (Rs.) | 66.39 | 52.42 | 52.02 | 49.91 | 38.71 |
| PBT / Share (Rs.) | 65.49 | 51.83 | 51.80 | 49.64 | 38.36 |
| Net Profit / Share (Rs.) | 48.67 | 38.50 | 39.65 | 38.07 | 30.02 |
| PBDIT Margin (%) | 34.80 | 30.62 | 31.22 | 31.80 | 27.64 |
| PBIT Margin (%) | 31.79 | 27.28 | 27.74 | 28.04 | 23.26 |
| PBT Margin (%) | 31.35 | 26.97 | 27.62 | 27.89 | 23.05 |
| Net Profit Margin (%) | 23.30 | 20.03 | 21.14 | 21.38 | 18.04 |
| Return on Networth / Equity (%) | 70.61 | 61.00 | 62.16 | 88.80 | 51.21 |
| Return on Capital Employeed (%) | 92.26 | 79.28 | 77.76 | 106.38 | 60.73 |
| Return On Assets (%) | 41.40 | 36.32 | 37.15 | 35.77 | 31.35 |
| Asset Turnover Ratio (%) | 1.87 | 1.81 | 1.76 | 1.76 | 1.73 |
| Current Ratio (X) | 1.54 | 1.43 | 1.37 | 0.84 | 1.16 |
| Quick Ratio (X) | 1.30 | 1.12 | 1.04 | 0.64 | 0.82 |
| Inventory Turnover Ratio (X) | 4.61 | 4.31 | 3.95 | 3.95 | 4.95 |
| Dividend Payout Ratio (NP) (%) | 88.35 | 101.29 | 47.92 | 141.85 | 66.62 |
| Dividend Payout Ratio (CP) (%) | 78.22 | 86.80 | 41.15 | 120.59 | 53.62 |
| Earning Retention Ratio (%) | 11.65 | -1.29 | 52.08 | -41.85 | 33.38 |
| Cash Earning Retention Ratio (%) | 21.78 | 13.20 | 58.85 | -20.59 | 46.38 |
| Interest Coverage Ratio (X) | 395.76 | 325.74 | 270.10 | 212.15 | 130.09 |
| Interest Coverage Ratio (Post Tax) (X) | 269.83 | 216.38 | 183.92 | 143.63 | 85.91 |
| Enterprise Value (Cr.) | 72358.90 | 40063.94 | 41171.93 | 41551.30 | 33657.22 |
| EV / Net Operating Revenue (X) | 12.74 | 7.67 | 8.07 | 8.58 | 7.44 |
| EV / EBITDA (X) | 36.59 | 25.03 | 25.86 | 26.98 | 26.91 |
| MarketCap / Net Operating Revenue (X) | 12.98 | 7.84 | 8.22 | 8.76 | 7.53 |
| Retention Ratios (%) | 11.64 | -1.29 | 52.07 | -41.85 | 33.37 |
| Price / BV (X) | 39.34 | 23.88 | 24.17 | 36.38 | 21.38 |
| Price / Net Operating Revenue (X) | 12.98 | 7.84 | 8.22 | 8.76 | 7.53 |
| EarningsYield | 0.01 | 0.02 | 0.02 | 0.02 | 0.02 |
After reviewing the key financial ratios for Colgate-Palmolive (India) Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 24, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 1.00.
- For Basic EPS (Rs.), as of Mar 24, the value is 48.67. This value is within the healthy range. It has increased from 38.50 (Mar 23) to 48.67, marking an increase of 10.17.
- For Diluted EPS (Rs.), as of Mar 24, the value is 48.67. This value is within the healthy range. It has increased from 38.50 (Mar 23) to 48.67, marking an increase of 10.17.
- For Cash EPS (Rs.), as of Mar 24, the value is 54.97. This value is within the healthy range. It has increased from 44.93 (Mar 23) to 54.97, marking an increase of 10.04.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 68.91. It has increased from 63.11 (Mar 23) to 68.91, marking an increase of 5.80.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 68.91. It has increased from 63.11 (Mar 23) to 68.91, marking an increase of 5.80.
- For Dividend / Share (Rs.), as of Mar 24, the value is 58.00. This value exceeds the healthy maximum of 3. It has increased from 39.00 (Mar 23) to 58.00, marking an increase of 19.00.
- For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 208.85. It has increased from 192.15 (Mar 23) to 208.85, marking an increase of 16.70.
- For PBDIT / Share (Rs.), as of Mar 24, the value is 72.70. This value is within the healthy range. It has increased from 58.85 (Mar 23) to 72.70, marking an increase of 13.85.
- For PBIT / Share (Rs.), as of Mar 24, the value is 66.39. This value is within the healthy range. It has increased from 52.42 (Mar 23) to 66.39, marking an increase of 13.97.
- For PBT / Share (Rs.), as of Mar 24, the value is 65.49. This value is within the healthy range. It has increased from 51.83 (Mar 23) to 65.49, marking an increase of 13.66.
- For Net Profit / Share (Rs.), as of Mar 24, the value is 48.67. This value is within the healthy range. It has increased from 38.50 (Mar 23) to 48.67, marking an increase of 10.17.
- For PBDIT Margin (%), as of Mar 24, the value is 34.80. This value is within the healthy range. It has increased from 30.62 (Mar 23) to 34.80, marking an increase of 4.18.
- For PBIT Margin (%), as of Mar 24, the value is 31.79. This value exceeds the healthy maximum of 20. It has increased from 27.28 (Mar 23) to 31.79, marking an increase of 4.51.
- For PBT Margin (%), as of Mar 24, the value is 31.35. This value is within the healthy range. It has increased from 26.97 (Mar 23) to 31.35, marking an increase of 4.38.
- For Net Profit Margin (%), as of Mar 24, the value is 23.30. This value exceeds the healthy maximum of 10. It has increased from 20.03 (Mar 23) to 23.30, marking an increase of 3.27.
- For Return on Networth / Equity (%), as of Mar 24, the value is 70.61. This value is within the healthy range. It has increased from 61.00 (Mar 23) to 70.61, marking an increase of 9.61.
- For Return on Capital Employeed (%), as of Mar 24, the value is 92.26. This value is within the healthy range. It has increased from 79.28 (Mar 23) to 92.26, marking an increase of 12.98.
- For Return On Assets (%), as of Mar 24, the value is 41.40. This value is within the healthy range. It has increased from 36.32 (Mar 23) to 41.40, marking an increase of 5.08.
- For Asset Turnover Ratio (%), as of Mar 24, the value is 1.87. It has increased from 1.81 (Mar 23) to 1.87, marking an increase of 0.06.
- For Current Ratio (X), as of Mar 24, the value is 1.54. This value is within the healthy range. It has increased from 1.43 (Mar 23) to 1.54, marking an increase of 0.11.
- For Quick Ratio (X), as of Mar 24, the value is 1.30. This value is within the healthy range. It has increased from 1.12 (Mar 23) to 1.30, marking an increase of 0.18.
- For Inventory Turnover Ratio (X), as of Mar 24, the value is 4.61. This value is within the healthy range. It has increased from 4.31 (Mar 23) to 4.61, marking an increase of 0.30.
- For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 88.35. This value exceeds the healthy maximum of 50. It has decreased from 101.29 (Mar 23) to 88.35, marking a decrease of 12.94.
- For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 78.22. This value exceeds the healthy maximum of 50. It has decreased from 86.80 (Mar 23) to 78.22, marking a decrease of 8.58.
- For Earning Retention Ratio (%), as of Mar 24, the value is 11.65. This value is below the healthy minimum of 40. It has increased from -1.29 (Mar 23) to 11.65, marking an increase of 12.94.
- For Cash Earning Retention Ratio (%), as of Mar 24, the value is 21.78. This value is below the healthy minimum of 40. It has increased from 13.20 (Mar 23) to 21.78, marking an increase of 8.58.
- For Interest Coverage Ratio (X), as of Mar 24, the value is 395.76. This value is within the healthy range. It has increased from 325.74 (Mar 23) to 395.76, marking an increase of 70.02.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 269.83. This value is within the healthy range. It has increased from 216.38 (Mar 23) to 269.83, marking an increase of 53.45.
- For Enterprise Value (Cr.), as of Mar 24, the value is 72,358.90. It has increased from 40,063.94 (Mar 23) to 72,358.90, marking an increase of 32,294.96.
- For EV / Net Operating Revenue (X), as of Mar 24, the value is 12.74. This value exceeds the healthy maximum of 3. It has increased from 7.67 (Mar 23) to 12.74, marking an increase of 5.07.
- For EV / EBITDA (X), as of Mar 24, the value is 36.59. This value exceeds the healthy maximum of 15. It has increased from 25.03 (Mar 23) to 36.59, marking an increase of 11.56.
- For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 12.98. This value exceeds the healthy maximum of 3. It has increased from 7.84 (Mar 23) to 12.98, marking an increase of 5.14.
- For Retention Ratios (%), as of Mar 24, the value is 11.64. This value is below the healthy minimum of 30. It has increased from -1.29 (Mar 23) to 11.64, marking an increase of 12.93.
- For Price / BV (X), as of Mar 24, the value is 39.34. This value exceeds the healthy maximum of 3. It has increased from 23.88 (Mar 23) to 39.34, marking an increase of 15.46.
- For Price / Net Operating Revenue (X), as of Mar 24, the value is 12.98. This value exceeds the healthy maximum of 3. It has increased from 7.84 (Mar 23) to 12.98, marking an increase of 5.14.
- For EarningsYield, as of Mar 24, the value is 0.01. This value is below the healthy minimum of 5. It has decreased from 0.02 (Mar 23) to 0.01, marking a decrease of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Colgate-Palmolive (India) Ltd:
- Net Profit Margin: 23.3%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 92.26% (Industry Average ROCE: 36.43%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 70.61% (Industry Average ROE: 29.37%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 269.83
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.3
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 46.1 (Industry average Stock P/E: 47.07)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 23.3%
About the Company - Qualitative Analysis
Colgate-Palmolive (India) Ltd. is a Public Limited Listed company incorporated on 23/09/1937 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L24200MH1937PLC002700 and registration number is 002700. Currently Company is involved in the business activities of Manufacture of other chemical products. Company's Total Operating Revenue is Rs. 5680.43 Cr. and Equity Capital is Rs. 27.20 Cr. for the Year ended 31/03/2024.
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Personal Care | Colgate Research Centre, Main Street, Mumbai Maharashtra 400076 | investors_grievance@colpal.com http://www.colgatepalmolive.co.in |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Mukul Deoras | Chairman |
| Ms. Prabha Narasimhan | Managing Director & CEO |
| Mr. M S Jacob | WholeTime Director & CFO |
| Mr. Surender Sharma | Whole Time Director |
| Mr. Sekhar Natarajan | Ind. Non-Executive Director |
| Ms. Gopika Pant | Ind. Non-Executive Director |
| Dr. Indu Bhushan | Ind. Non-Executive Director |
| Mr. Sanjay Gupta | Ind. Non-Executive Director |
| Ms. Sukanya Kripalu | Ind. Non-Executive Director |
FAQ
What is the latest intrinsic value of Colgate-Palmolive (India) Ltd?
The latest intrinsic value of Colgate-Palmolive (India) Ltd as on 09 March 2025 is ₹1703.43, which is 31.15% lower than the current market price of 2,474.00, indicating the stock is overvalued by 31.15%. The intrinsic value of Colgate-Palmolive (India) Ltd is calculated using PE ratio method. The stock has a market capitalization of ₹67,284 Cr. and recorded a high/low of ₹3,893/2,361 during the current fiscal year 2024-2025. As of Sep 2024, the company has reserves of ₹1,626 Cr and total liabilities of ₹3,248 Cr.
What is the Market Cap of Colgate-Palmolive (India) Ltd?
The Market Cap of Colgate-Palmolive (India) Ltd is 67,284 Cr..
What is the current Stock Price of Colgate-Palmolive (India) Ltd as on 09 March 2025?
The current stock price of Colgate-Palmolive (India) Ltd as on 09 March 2025 is ₹2,474.
What is the High / Low of Colgate-Palmolive (India) Ltd stocks in FY 2024-2025?
In FY 2024-2025, the High / Low of Colgate-Palmolive (India) Ltd stocks is ₹3,893/2,361.
What is the Stock P/E of Colgate-Palmolive (India) Ltd?
The Stock P/E of Colgate-Palmolive (India) Ltd is 46.1.
What is the Book Value of Colgate-Palmolive (India) Ltd?
The Book Value of Colgate-Palmolive (India) Ltd is 60.8.
What is the Dividend Yield of Colgate-Palmolive (India) Ltd?
The Dividend Yield of Colgate-Palmolive (India) Ltd is 1.97 %.
What is the ROCE of Colgate-Palmolive (India) Ltd?
The ROCE of Colgate-Palmolive (India) Ltd is 96.8 %.
What is the ROE of Colgate-Palmolive (India) Ltd?
The ROE of Colgate-Palmolive (India) Ltd is 74.5 %.
What is the Face Value of Colgate-Palmolive (India) Ltd?
The Face Value of Colgate-Palmolive (India) Ltd is 1.00.